Grupo Argos Valuation
Is GRPARGOSCL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GRPARGOSCL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GRPARGOSCL (CLP3075) is trading above our estimate of fair value (CLP2140.96)
Significantly Below Fair Value: GRPARGOSCL is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GRPARGOSCL?
Other financial metrics that can be useful for relative valuation.
What is GRPARGOSCL's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | Col$13.27t |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.5x |
Enterprise Value/EBITDA | 6.4x |
PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does GRPARGOSCL's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 9.4x | ||
CEMENTOS Cementos Bio Bio | 6.4x | n/a | CL$185.5b |
VOLCAN Compañía Industrial El Volcán | 9.6x | n/a | CL$182.3b |
CMPC Empresas CMPC | 10.4x | 3.0% | CL$4.6t |
ENAEX Enaex | 11.4x | n/a | CL$1.7t |
GRPARGOSCL Grupo Argos | 15.6x | 11.8% | CL$13.3t |
Price-To-Earnings vs Peers: GRPARGOSCL is expensive based on its Price-To-Earnings Ratio (15.6x) compared to the peer average (9.4x).
Price to Earnings Ratio vs Industry
How does GRPARGOSCL's PE Ratio compare vs other companies in the Global Basic Materials Industry?
Price-To-Earnings vs Industry: GRPARGOSCL is expensive based on its Price-To-Earnings Ratio (15.6x) compared to the Global Basic Materials industry average (15.6x).
Price to Earnings Ratio vs Fair Ratio
What is GRPARGOSCL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 15.6x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate GRPARGOSCL's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CL$3,075.00 | CL$3,593.99 +16.9% | 18.6% | CL$4,421.48 | CL$2,865.31 | n/a | 4 |
Apr ’25 | CL$3,075.00 | CL$3,593.99 +16.9% | 18.6% | CL$4,421.48 | CL$2,865.31 | n/a | 4 |
Mar ’25 | CL$3,075.00 | CL$3,631.95 +18.1% | 18.6% | CL$4,468.17 | CL$2,895.57 | n/a | 4 |
Feb ’25 | CL$3,075.00 | CL$3,484.25 +13.3% | 18.6% | CL$4,286.47 | CL$2,777.82 | n/a | 4 |
Jan ’25 | CL$3,010.40 | CL$2,890.67 -4.0% | 19.6% | CL$3,868.63 | CL$2,507.05 | n/a | 4 |
Dec ’24 | CL$3,010.40 | CL$2,890.67 -4.0% | 19.6% | CL$3,868.63 | CL$2,507.05 | n/a | 4 |
Nov ’24 | CL$3,010.40 | CL$2,758.05 -8.4% | 4.7% | CL$2,968.50 | CL$2,614.06 | n/a | 4 |
Oct ’24 | CL$3,010.40 | CL$2,758.05 -8.4% | 4.7% | CL$2,968.50 | CL$2,614.06 | n/a | 4 |
Sep ’24 | CL$3,010.40 | CL$2,744.79 -8.8% | 4.1% | CL$2,903.70 | CL$2,643.67 | n/a | 3 |
Aug ’24 | CL$3,010.40 | CL$2,443.94 -18.8% | 4.1% | CL$2,585.43 | CL$2,353.90 | n/a | 3 |
Jul ’24 | CL$3,010.40 | CL$2,313.22 -23.2% | 8.4% | CL$2,618.74 | CL$2,129.91 | n/a | 4 |
Jun ’24 | CL$3,010.40 | CL$2,313.22 -23.2% | 8.4% | CL$2,618.74 | CL$2,129.91 | n/a | 4 |
May ’24 | CL$3,010.40 | CL$2,313.22 -23.2% | 8.4% | CL$2,618.74 | CL$2,129.91 | n/a | 4 |
Apr ’24 | CL$3,010.40 | CL$2,313.22 -23.2% | 8.4% | CL$2,618.74 | CL$2,129.91 | CL$3,075.00 | 4 |
Mar ’24 | CL$3,010.40 | CL$2,313.22 -23.2% | 8.4% | CL$2,618.74 | CL$2,129.91 | CL$3,075.00 | 4 |
Feb ’24 | CL$3,010.40 | CL$2,448.31 -18.7% | 8.4% | CL$2,771.67 | CL$2,254.29 | CL$3,075.00 | 4 |
Jan ’24 | CL$3,010.40 | CL$2,448.31 -18.7% | 8.4% | CL$2,771.67 | CL$2,254.29 | CL$3,010.40 | 4 |
Dec ’23 | CL$3,010.40 | CL$2,448.31 -18.7% | 8.4% | CL$2,771.67 | CL$2,254.29 | CL$3,010.40 | 4 |
Nov ’23 | CL$3,010.40 | CL$2,866.23 -4.8% | 9.9% | CL$3,149.71 | CL$2,561.76 | CL$3,010.40 | 4 |
Oct ’23 | CL$3,010.40 | CL$3,127.28 +3.9% | 12.8% | CL$3,681.61 | CL$2,552.03 | CL$3,010.40 | 4 |
Sep ’23 | CL$3,010.40 | CL$3,162.19 +5.0% | 14.8% | CL$3,726.87 | CL$2,583.40 | CL$3,010.40 | 3 |
Aug ’23 | CL$3,010.40 | CL$3,002.73 -0.3% | 11.4% | CL$3,349.47 | CL$2,538.11 | CL$3,010.40 | 3 |
Jul ’23 | CL$2,955.00 | CL$3,002.73 +1.6% | 11.4% | CL$3,349.47 | CL$2,538.11 | CL$3,010.40 | 3 |
Jun ’23 | CL$2,955.00 | CL$3,002.73 +1.6% | 11.4% | CL$3,349.47 | CL$2,538.11 | CL$3,010.40 | 3 |
May ’23 | CL$3,103.50 | CL$3,002.73 -3.2% | 11.4% | CL$3,349.47 | CL$2,538.11 | CL$3,010.40 | 3 |
Apr ’23 | CL$2,998.30 | CL$3,002.73 +0.1% | 11.4% | CL$3,349.47 | CL$2,538.11 | CL$3,010.40 | 3 |
Analyst Forecast: Target price is lower than the current share price.